A Close Look at Washington's Next $50 billion for HIV/AIDS, TB and Malaria
Similar versions of a bill authorizing $50 billion for global HIV/AIDS, malaria and TB programs over the next five years recently passed House and Senate committees and will be sent to the floor for a vote. CGD's HIV/AIDS Monitor director Nandini Oomman reports that the bills respond to some of the evidence from the first five years of the President's Emergency Plan for AIDS Relief (PEPFAR) regarding funding allocations, the strengthening of local capacity, the unique vulnerabilities of women and girls, and the need for better monitoring and impact evaluation. The Senate bill also supports U.S. backing of advance market commitments for vaccines, an idea that a CGD working group helped to develop. The bills are less clear on such controversial issues as family planning and the so-called anti-prostitution pledge.